Corrigendum to "Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis" [Eur. J. Pharmacol. 779 (2016) 20-30 doi: 10.1016/j.ejphar.2016.02.067]

Affiliations

• ¹ Hepatology Institute of Wenzhou Medical University, Wenzhou Key Laboratory of Hepatology, Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
• ² Li Ka Shing Faculty of Medicine, University of Hong Kong, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Zhejiang University, Hangzhou, China.
• ³ Chemical Biology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
• ⁴ Liver Cancer Therapy and Research Center, People's Liberation Army 302 Hospital, Beijing, 100039, China.
• ⁵ Hepatology Institute of Wenzhou Medical University, Wenzhou Key Laboratory of Hepatology, Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Medicine, University of Louisville School of Medicine, Louisville, KY, 40202, USA. Electronic address: [email protected].
• ⁶ Hepatology Institute of Wenzhou Medical University, Wenzhou Key Laboratory of Hepatology, Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: [email protected].